Scientists believe the illegal drug MDMA, also known as ecstasy, has an untapped potential to treat post-traumatic stress disorder (PTSD). But they say plans to test the drug on war veterans in [...]
This presentation was delivered by PRISM Vice-President Dr Stephen Bright at a fundraising seminar and dinner held at The Melbourne Brain Centre, Parkville on 8th April 2016.
Dr Stephen Bright talks to The Psychedelia Podcast about the problems facing the psychedelic movement in Australia
Dr Stephen Bright, a Psychologist working at Curtin University discusses psychedelic therapy.
In September 2016 PRISM’s Vice President Dr Stephen Bright spoke at Beyond Psychedelics, a global multidisciplinary psychedelic forum held in Prague, Czech Republic.
A recent review in Pharmacological Reviews highlights that over the last decade, a renaissance has occurred in psychedelic drug research
Click here to listen: https://soundcloud.com/enpsychedelia/the-psychedelic-inquirer-prism-interview
Some drugs that have therapeutic benefits are banned because of emerging patterns of use that do not conform to dominant paradigms. Such policies are often driven by morality rather than evidence.
PRISM will be presenting a panel discussion at the 2013 Australian Professional Society on Alcohol and other Drugs Scientific Conference 24-27 November in Brisbane.